Skip to main content

Nissui Pharmaceutical Co.,Ltd.

日水製薬株式会社

Valuation

Fundamental ratios for the latest reported period.

Ticker: 4550
FY2021 · 2022-03-31
Gross margin31.6%
Operating margin9.4%
Net margin6.9%
Return on equity3.5%
Return on assets3.1%
Revenue growth (YoY)34.5%
EPS (basic)¥51.2
EPS growth (YoY)76.9%
Current ratio8.29x
Equity ratio87.9%
Book value / share¥1,455.97
Free cash flow957 M